Perineal urethrostomy (PU) is often the definitive form of urinary diversion in patients with locally-advanced or anatomically unfavorable penile cancer (PC) requiring total penectomy. Here, we report post-operative PU-related complications and PU stenosis rates after total penectomy with PU in a large multicenter cohort of PC patients.
We retrospectively reviewed the medical records of 299 patients who underwent PU as a means of urinary diversion for primary PC across seven international centers from 2000 to 2020. The Clavien-Dindo grading system was used to record 30-day post-operative complications. Cumulative incidence of stenosis was evaluated using the Kaplan-Meier method.
Median patient age was 67 years (interquartile range (IQR) 58-74), and median follow-up was 19 months (IQR 7.2-57). A total of 58 patients (19%) developed a 30-day post-operative complication, of which 45 (79%) were deemed minor (CD Grade I and II). Wound infection (11%; CD grade I-III) and dehiscence (4.0%; CD grade I-III) were the more common complications. The overall incidence of stenosis was 12% (35/299 patients), of which 26 (74%) needed surgical revision (probability of stenosis revision at one year of 9.3%, median time until the revision: 6.1 months (IQR 3.0-13)). Only two stenoses were seen after two years of follow-up.
We present the most extensive series of PU in the management of PC to date. Wound infections of the primary surgical site were the most common complication. Stenosis occurred mostly within one and a half years after treatment.
Urologic oncology. 2021 Jun 13 [Epub ahead of print]
Hielke M de Vries, Juan Chipollini, Julio Slongo, Franklin Boyd, Fernando Korkes, Maarten Albersen, Eduard Roussel, Yao Zhu, Ding-Wei Ye, Viraj Master, Thien-Linh Le, Peter A Johnstone, Asif Muneer, Oscar R Brouwer, Philippe E Spiess
Department of Urology, The Netherlands Cancer Institute, Amsterdam, Netherlands., Department of Urology, University of Arizona, Tucson, AZ., Department of Urology, University of South Florida, Tampa, FL., Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, FL., Departamento de Urologia, Faculdade de Medicina do ABC, São Paulo, Brazil., Department of Urology, University Hospitals Leuven, Leuven, Belgium., Department of Urology, Fudan University Shanghai Cancer Center, Shanghai, People's Republic of China., Department of Urology, Emory University, Atlanta, GA., Department of Radiation Oncology, Moffitt Cancer Center, Tampa, FL., Department of Urology, University College London Hospital, London, United Kingdom., Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, FL. Electronic address: .
PubMed http://www.ncbi.nlm.nih.gov/pubmed/34134926